Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Gilead Sciences Inc (GILD)

  • SEC News
  • Jan. 16, 2026, 23:10 UTC
  • 1
  • 1 comments

Mercier Johanna 🔴 sold 3.0K shares of GILEAD SCIENCES, INC. (GILD) at $124.31 Transaction Date: Jan 15, 2026 | Filing ID: 000002

Comment Full text

InspireMD Inc (NSPR)

  • SEC News
  • Jan. 16, 2026, 23:10 UTC
  • 1
  • 1 comments

Lawless Michael A 🟢 acquired 226.7K shares of InspireMD, Inc. (NSPR) Transaction Date: Jan 14, 2026 | Filing ID: 002666

Comment Full text

InspireMD Inc (NSPR)

  • SEC News
  • Jan. 16, 2026, 23:09 UTC
  • 1
  • 1 comments

Gleason Shane Thomas 🟢 acquired 453.4K shares of InspireMD, Inc. (NSPR) Transaction Date: Jan 14, 2026 | Filing ID: 002665

Comment Full text

InspireMD Inc (NSPR)

  • SEC News
  • Jan. 16, 2026, 23:09 UTC
  • 1
  • 1 comments

Director Dearen Danny L. 🟢 acquired 44.0K shares of InspireMD, Inc. (NSPR) Transaction Date: Jan 14, 2026 | Filing ID: 002664

Comment Full text

InspireMD Inc (NSPR)

  • SEC News
  • Jan. 16, 2026, 23:09 UTC
  • 1
  • 1 comments

Director COHEN RAYMOND W 🟢 acquired 44.0K shares of InspireMD, Inc. (NSPR) Transaction Date: Jan 14, 2026 | Filing ID: 002663

Comment Full text

InspireMD Inc (NSPR)

  • SEC News
  • Jan. 16, 2026, 23:09 UTC
  • 1
  • 1 comments

Director BERMAN MICHAEL 🟢 acquired 88.1K shares of InspireMD, Inc. (NSPR) Transaction Date: Jan 14, 2026 | Filing ID: 002662

Comment Full text

Werewolf Therapeutics Inc (HOWL)

  • SEC News
  • Jan. 16, 2026, 22:43 UTC
  • 20
  • 0 comments

New Form SCHEDULE 13D/A - Werewolf Therapeutics, Inc. Filed: 2026-01-16 AccNo: 0001609492-26-000002 Size: 40 KB

Comment Full text

Celcuity Inc. (CELC)

  • SEC News
  • Jan. 16, 2026, 22:35 UTC
  • 14
  • 0 comments

New Form SCHEDULE 13D/A - Celcuity Inc. Filed: 2026-01-16 AccNo: 0001072613-26-000056 Size: 110 KB

Comment Full text

Neurocrine Biosciences Inc (NBIX)

  • SEC News
  • Jan. 16, 2026, 22:18 UTC
  • 14
  • 0 comments

New Form 4/A - NEUROCRINE BIOSCIENCES INC Filed: 2026-01-16 AccNo: 0001643653-26-000005 Size: 8 KB

Comment Full text

Artelo Biosciences Inc. (ARTLW)

  • SEC News
  • Jan. 16, 2026, 22:16 UTC
  • 1
  • 1 comments

(99% Neutral) Artelo Biosciences Inc. (ARTLW) Files Form 8-K

Comment Full text

Heart Test Laboratories Inc (HSCSW)

  • SEC News
  • Jan. 16, 2026, 22:15 UTC
  • 1
  • 1 comments

(99% Neutral) Heart Test Laboratories Inc (HSCSW) Announces Business Combination

Comment Full text

Iovance Biotherapeutics Inc (IOVA)

  • Business News
  • Jan. 16, 2026, 22:15 UTC
  • 6
  • 1 comments

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Market reaction Comment Full text

Aethlon Medical Inc (AEMD)

  • SEC News
  • Jan. 16, 2026, 22:14 UTC
  • 15
  • 0 comments

New Form 424B3 - AETHLON MEDICAL INC Filed: 2026-01-16 AccNo: 0001683168-26-000376 Size: 294 KB

Comment Full text

Repare Therapeutics Inc (RPTX)

  • SEC News
  • Jan. 16, 2026, 22:10 UTC
  • 1
  • 1 comments

(99% Neutral) Repare Therapeutics Inc (RPTX) Files Form 8-K

Comment Full text

Vaxcyte Inc (PCVX)

  • SEC News
  • Jan. 16, 2026, 22:10 UTC
  • 1
  • 1 comments

Director PICKERING GRANT 🔴 sold 100.0K shares of Vaxcyte, Inc. (PCVX) Transaction Date: Jan 14, 2026 | Filing ID: 000002

Comment Full text
  • Previous
  • 129
  • 130
  • 131
  • 132
  • 133
  • Next

Search

News categories

  • Technical Exchange News(10870)
  • Event(2243)
  • SEC News(189155)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124506)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin